Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS1 | P29475 | 3/20 | 0.52 |
| ▸ | AOC3 | Q16853 | 4/20 | 0.50 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.48 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.46 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.46 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.46 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.46 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.46 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.46 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.46 |
| ▸ | IDO1 | P14902 | 3/20 | 0.45 |
| ▸ | NOS3 | P29474 | 1/20 | 0.45 |
| ▸ | NOS2 | P35228 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.43 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.43 |
| ▸ | HTR2A | P28223 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.43 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28600447 | 0.82 | ESR1 (0.50) | NOS1TAAR1IDO1TDP1OPRK1 | |
| SCHEMBL10592047 | 0.82 | AOC3 (0.55) | NOS1AOC3TAAR1GRIN2DGRIN3B | |
| SCHEMBL3926231 | 0.82 | ALOX5 (0.51) | NOS1AOC3TAAR1GRIN2DGRIN3B | |
| SCHEMBL3916717 | 0.80 | NOS1 (0.48) | NOS1AOC3TAAR1GRIN2DGRIN3B | |
| SCHEMBL3998820 | 0.80 | NOS1 (0.48) | NOS1AOC3TAAR1GRIN2DGRIN3B | |
| SCHEMBL17887716 | 0.79 | GRIN2D (0.64) | NOS1AOC3TAAR1GRIN2DGRIN3B | |
| SCHEMBL3690613 | 0.78 | GRIN2D (0.58) | NOS1AOC3GRIN2DGRIN3BGRIN1 | |
| SCHEMBL6137843 | 0.77 | TDP1 (0.45) | NOS1GRIN2DGRIN3BGRIN1GRIN2A | |
| SCHEMBL15955098 | 0.76 | KMT2A (0.49) | AOC3TAAR1TDP1SMN1; SMN2OPRK1 | |
| SCHEMBL11643863 | 0.76 | NOS1 (0.44) | NOS1AOC3TAAR1GRIN2DGRIN3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4180482-B1 | MOISTURE-CURABLE COMPOSITION | NITTO KASEI CO LTD (JP) | 2025-12-03 | — | — | EP | disclosed |
| US-12479869-B2 | Curing catalyst used for curing of polymer, method for producing same, moisture-curable composition, and method for producing cured product | NITTO KASEI CO., LTD. (JP) | 2025-11-25 | — | — | US | disclosed |
| EP-4174053-B1 | CURING CATALYST USED FOR CURING OF POLYMER, METHOD FOR PRODUCING SAME, MOISTURE-CURABLE COMPOSITION, AND METHOD FOR PRODUCING CURED PRODUCT | NITTO KASEI CO LTD (JP) | 2025-11-19 | — | — | EP | disclosed |
| EP-4569023-A1 | COMBINATION OF CATALYTIC COMPONENTS | PolyU GmbH (DE) | 2025-06-18 | — | — | EP | disclosed |
| CN-115516041-B | Curing catalyst for curing polymer, method for producing same, moisture-curable composition, and method for producing cured product | 日东化成株式会社 | 2024-06-28 | — | — | CN | disclosed |
| WO-2024033348-A1 | COMBINATION OF CATALYTIC COMPONENTS | POLYU GMBH (DE) | 2024-02-15 | — | — | WO | disclosed |
| EP-4321573-A1 | COMBINATION OF CATALYTIC COMPONENTS | PolyU GmbH (DE) | 2024-02-14 | — | — | EP | disclosed |
| US-20230234976-A1 | CURING CATALYST USED FOR CURING OF POLYMER, METHOD FOR PRODUCING SAME, MOISTURE-CURABLE COMPOSITION, AND METHOD FOR PRODUCING CURED PRODUCT | NITTO KASEI CO., LTD. (JP) | 2023-07-27 | — | — | US | disclosed |
| EP-4180482-A1 | MOISTURE-CURABLE COMPOSITION | Nitto Kasei Co., Ltd. (JP) | 2023-05-17 | — | — | EP | disclosed |
| EP-4174053-A1 | CURING CATALYST USED FOR CURING OF POLYMER, METHOD FOR PRODUCING SAME, MOISTURE-CURABLE COMPOSITION, AND METHOD FOR PRODUCING CURED PRODUCT | Nitto Kasei Co., Ltd. (JP) | 2023-05-03 | — | — | EP | disclosed |
| US-20150099849-A1 | CURABLE COMPOSITION, AND CURED SYNTHETIC RESIN USING SAME | MIE UNIVERSITY (JP) | 2015-04-09 | — | — | US | disclosed |
| EP-2837660-A1 | CURABLE COMPOSITION, AND CURED SYNTHETIC RESIN USING SAME | Mie University (JP) | 2015-02-18 | — | — | EP | disclosed |
| EP-2388297-A1 | CURABLE COMPOSITION AND CURED OBJECT FORMED THEREFROM | Kaneka Corporation (JP) | 2011-11-23 | — | — | EP | disclosed |
| US-8013079-B2 | Curable composition | KANEKA CORPORATION (JP) | 2011-09-06 | — | — | US | disclosed |
| EP-2267083-A1 | CURABLE COMPOSITION AND CURED MATERIAL | Kaneka Corporation (JP) | 2010-12-29 | — | — | EP | disclosed |
| EP-1988127-B1 | CURABLE COMPOSITION | KANEKA CORP (JP) | 2010-12-15 | — | — | EP | disclosed |
| US-20100036049-A1 | CURABLE COMPOSITION | KANEKA CORPORATION | 2010-02-11 | — | — | US | disclosed |
| US-20090182091-A1 | CURABLE COMPOSITION | KANEKA CORPORATION (JP) | 2009-07-16 | — | — | US | disclosed |
| EP-1988127-A1 | CURABLE COMPOSITION | Kaneka Corporation (JP) | 2008-11-05 | — | — | EP | disclosed |
| EP-1939257-A1 | CURABLE COMPOSITION | Kaneka Corporation (JP) | 2008-07-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12479869-B2 | Curing catalyst used for curing of polymer, method for producing same, moisture-curable composition, and method for producing cured product | KDM2B, SETDB1, ASH2L | NOS1 25/4885AOC3 436/4885TAAR1 1278/4885 |
| US-20230234976-A1 | CURING CATALYST USED FOR CURING OF POLYMER, METHOD FOR PRODUCING SAME, MOISTURE-CURABLE COMPOSITION, AND METHOD FOR PRODUCING CURED PRODUCT | KDM2B, SETDB1, ASH2L | NOS1 25/4885AOC3 436/4885TAAR1 1278/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.